Skip to main content

Table 1 Baseline data at the start of dialysis

From: Higher mortality of patients on haemodialysis with pancreatic diabetes compared to type 2-diabetes

 

Pancreatic diabetes

Type 2 diabetes

 

(n = 12)

(n = 84)

Age (years)

56 ± 6*

63 ± 8*

Sex (female %)

50%

52%

Diabetes duration (years)

17 ± 7

18 ± 6

HbA1c (%)

7.5 ± 1.3

7.6 ± 1.1

Body weight (kg)

59 ± 7**

70 ± 11**

BMI (kg/m2)

22 ± 3*

25 ± 4*

C-peptide basal (ng/ml)

0.9 ± 0.3*

1.9 ± 0.6*

Systolic blood pressure (mm Hg)

136 ± 12

137 ± 10

Diastolic blood pressure (mm Hg)

86 ± 9

87 ± 8

Antidiabetic therapy (%)

  

Diet and sulfonylurea

0

5%

Conventional insulin therapy

50%

44%

Intensified insulin therapy

50%

41%

Insulin dose (IU/day)

22+11*

32+11*

Vascular access (n/%)

  

Arteriovenous fistula

10 (83%)

64 (76%)

Permcath-dialysis catheter

2 (17/%)

20 (24%)

Insulin dose (IU/day)

22 ± 11*

32 ± 16*

Duration of dialysis (hours//week)

13 (12-15)

13 (12-15)

Kt/V (three month after start of HD)

1.3

1.4

  1. p < 0.05, **p < 0.01. Data are expressed as x+SD, x (range) or %